CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Fouad ChoueiryMolly TorokReena ShakyaKriti AgrawalAnna DeemsBrooke BennerAlice HintonJami ShafferBradley W BlaserAnne M NoonanTerence M WilliamsMary DillhoffDarwin L ConwellPhil A HartZobeida Cruz-MonserrateXue-Feng BaiWilliam E CarsonThomas A MacePublished in: Journal for immunotherapy of cancer (2020)
These results indicate that CD200 expression in the PDAC microenvironment may regulate MDSC expansion and that targeting CD200 may enhance activity of checkpoint immunotherapy.